AzTrials
AzTrials

Any Symptoms Requiring ColonoscopyNCT02092493

The Effect of ScopeGuide on the Mental Workload of Endoscopist

A study testing ScopeGuide in people with Any Symptoms Requiring Colonoscopy, run by University Hospital Southampton NHS Foundation Trust at 1 site in United Kingdom.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

ScopeGuide (Magnetic endoscopic imaging) is a device used during some colonoscopies which provides real-time 3D image of the shape and configuration of the colonoscope as it travels through the colon. Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Any Symptoms Requiring Colonoscopy
What is being tested?
ScopeGuide
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited Kingdom
Study dates
Apr 2014to Apr 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All endoscopist performing colonoscopy at University hospital Southampton endoscopy unit
  • All adult patients attending diagnostic colonoscopy

Who cannot join

  • Endoscopist preference
  • Patients unable to give informed consent
  • Patient preference
  • Patients with new diagnosis of colonic cancer

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University Hospital Southampton

    Southampton, Hamshire, SO16 6YD

Other trials in United Kingdom

About this study

Official title: The Effect of Magnetic Endoscopic Imaging (ScopeGuide) on the Mental Workload of Endoscopists During Colonoscopy

ScopeGuide (Magnetic endoscopic imaging) is a device used during some colonoscopies which provides real-time 3D image of the shape and configuration of the colonoscope as it travels through the colon. Whilst it is being used in clinical practice in most units in the UK, it is not a device which is routinely used on all lists, and most departments do not own enough ScopeGuides to have on all lists. Studies have shown it can potentially aid colonoscopy by improving completion rates and times as well as patient comfort in selected endoscopists (persons who perform the colonoscopy). However data on its benefit have been conflicting.

Subjective mental workload (the individuals mental resources required as a result of the multiple demands placed on him/her from a task)in healthcare employees is known to be important for the performance and safety of healthcare delivery. Increased workload during task performance may increase fatigue, facilitate errors and lead to overall inferior performance.

Read more

In colonoscopy high mental workload could potentially be responsible for longer procedural time, lack of trainee learning, inadvertent missing of lesions in the bowel as well as poor technique leading to patient discomfort. The effect of the endoscopist mental workload on their performance and potential facilitators to reduce mental workload is an area that has been neglected in this field.

This study aims to look at the mental workload of endoscopist during colonoscopy and the effect ScopeGuide may have on this workload.

Hypothesis: The use of ScopeGuide during colonoscopy will reduce the mental workload of the endoscopist performing the procedure

Being tested
ScopeGuide
Keywords
ScopeGuide, Colonoscopy, Mental workload

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ScopeGuideDevice

    Also called Magnetic endoscopic imaging

    These patient will have their procedure undertake with the use of ScopeGuide, which provides a 3d configuration of the colonoscope in the patient

Study groups in NCT02092493
Study groupRoleWhat they receive
Non-ScopeGuideNo interventionThis arm will have patients undertaking the procedure without ScopeGuide. All outcome measures will be recorded as usual
ScopeGuideExperimentalPatients have their colonoscopy done with ScopeGuide
Receives: Device: ScopeGuide

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mental workload scores for endoscopist performing colonoscopy (represented by the NASA-task load index scores on a visual analogue scale (VAS) ranging from 0-600)

    This will be a brief VAS scale questionnaire carried out when the endoscopist reaches the caecum

    Measured: within 1 hour of beginning procedure

  2. Caecal intubation times, recorded in minutes and seconds

    this would be the time it takes from the beginning of the procedure to reaching the caecum

    Measured: within 1 hour of beginning procedure

Secondary outcomes (7)
  1. Withdrawal time measured in minutes and second

    Measured: within 1 hour of beginning procedure

  2. Overall procedure times in minutes and seconds

    Measured: within 1 hour of beginning procedure

  3. -'Timing' of procedures (day & am/pm & order on list)

    Measured: upto 1 hour before beginning procedure

  4. Polyp detection

    Measured: within 1 hour of beginning procedure

  5. Patient comfort scores on a visual analogue scale

    Measured: within 1 hour of completing procedure

  6. Sedation dose measured in milligrams and micrograms

    Measured: within 1 hour of completing procedure

  7. Patient pre-endoscopy anxiety levels measured on visual analogue scale

    Measured: upto 1 hour before beginning procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionApr 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02092493
Sponsor's protocol ID
MEI1
Status last verified
Oct 2016
First submitted
12 Mar 2014
Last updated
13 Oct 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing ScopeGuide in people with Any Symptoms Requiring Colonoscopy, run by University Hospital Southampton NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 13 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mental workload scores for endoscopist performing colonoscopy (represented by the NASA-task load index scores on a visual analogue scale (VAS) ranging from 0-600) (time frame: within 1 hour of beginning procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in